Search Results - "Al Husseini, Aysar"

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis by Nicolls, Mark R., Mizuno, Shiro, Taraseviciene-Stewart, Laima, Farkas, Laszlo, Drake, Jennifer I., Al Husseini, Aysar, Gomez-Arroyo, Jose G., Voelkel, Norbert F., Bogaard, Herman J.

“…In spite of treatment, severe angioproliferative pulmonary arterial hypertension (PAH) remains a disease characterized by great morbidity and shortened…”
Get full text

Severe pulmonary hypertension: The role of metabolic and endocrine disorders by Bogaard, Harm J., Husseini, Aysar Al, Farkas, Laszlo, Farkas, Daniela, Gomez-Arroyo, Jose, Abbate, Antonio, Voelkel, Norbert F.

“…Pulmonary arterial hypertension (PAH) is a multi-factorial condition and the underlying pulmonary vascular disease is shaped by the combined action of genetic,…”
Get full text

Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension? by Voelkel, Norbert F, Bogaard, Harm J, Al Husseini, Aysar, Farkas, Laszlo, Gomez-Arroyo, Jose, Natarajan, Ramesh

“…Pathobiological mechanisms that contribute to pulmonary vasoconstriction, lung vascular remodeling, and the development of right heart failure include the…”
Get more information

Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension by Al-Husseini, Aysar, Wijesinghe, Dayanjan S, Farkas, Laszlo, Kraskauskas, Donatas, Drake, Jennifer I, Van Tassel, Ben, Abbate, Antonio, Chalfant, Charles E, Voelkel, Norbert F

“…Inflammation and altered immunity are recognized components of severe pulmonary arterial hypertension in human patients and in animal models of PAH. While…”
Get full text

Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization by Mizuno, Shiro, Farkas, Laszlo, Al Husseini, Aysar, Farkas, Daniela, Gomez-Arroyo, Jose, Kraskauskas, Donatas, Nicolls, Mark R., Cool, Carlyne D., Bogaard, Herman J., Voelkel, Norbert F.

Get full text

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization by Mizuno, Shiro, Farkas, Laszlo, Al Husseini, Aysar, Farkas, Daniela, Gomez-Arroyo, Jose, Kraskauskas, Donatas, Nicolls, Mark R, Cool, Carlyne D, Bogaard, Herman J, Voelkel, Norbert F

“…The combination of chronic hypoxia and treatment of rats with the vascular endothelial growth factor (VEGF) receptor blocker, SU5416, induces pulmonary…”
Get full text

Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats by AL HUSSEINI, Aysar, BAGNATO, Gianluca, JAN BOGAARD, Harm, FARKAS, Laszlo, GOMEZ-ARROYO, Jose, FARKAS, Daniela, MIZUNO, Shiro, KRASKAUSKAS, Donatas, ABBATE, Antonio, VAN TASSEL, Benjamin, VOELKEL, Norbert F

“…Epidemiological evidence links pulmonary arterial hypertension (PAH) with thyroid disease, but a mechanistic explanation for this association is lacking…”
Get full text

Abstract 13407: A Mouse Model of Heart Failure with Preserved Ejection Fraction (HFpEF) due to Chronic Infusion of a Low Subpressor Dose of Angiotensin II by Toldo, Stefano, Marchetti, Carlo, Al Husseini, Aysar, Carbone, Salvatore, Regan, Jessica, Mauro, Alfonso G, Nordio, Andrea, Sonnino, Chiara, Mezzaroma, Eleonora, Van Tassell, Benjamin W, Abbate, Antonio

“…Abstract only Introduction: Heart failure with preserved ejection fracture (HFpEF) is a clinical syndrome of HF symptoms associated with impaired diastolic…”
Get full text